Cargando…
Correction: EGFR kinase domain mutation positive lung cancers are sensitive to intrapleural perfusion with hyperthermic chemotherapy (IPHC) complete treatment
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219665/ https://www.ncbi.nlm.nih.gov/pubmed/30443297 http://dx.doi.org/10.18632/oncotarget.26255 |
| _version_ | 1783368694177464320 |
|---|---|
| author | Zhang, Hongjuan Zhan, Cheng Ke, Ji Xue, Zhiqiang Zhang, Aiqun Xu, Kaifeng Shen, Zhirong Yu, Lei Chen, Liang |
| author_facet | Zhang, Hongjuan Zhan, Cheng Ke, Ji Xue, Zhiqiang Zhang, Aiqun Xu, Kaifeng Shen, Zhirong Yu, Lei Chen, Liang |
| author_sort | Zhang, Hongjuan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6219665 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Impact Journals LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-62196652018-11-15 Correction: EGFR kinase domain mutation positive lung cancers are sensitive to intrapleural perfusion with hyperthermic chemotherapy (IPHC) complete treatment Zhang, Hongjuan Zhan, Cheng Ke, Ji Xue, Zhiqiang Zhang, Aiqun Xu, Kaifeng Shen, Zhirong Yu, Lei Chen, Liang Oncotarget Correction Impact Journals LLC 2018-10-16 /pmc/articles/PMC6219665/ /pubmed/30443297 http://dx.doi.org/10.18632/oncotarget.26255 Text en Copyright: © 2018 Gunathilake et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Correction Zhang, Hongjuan Zhan, Cheng Ke, Ji Xue, Zhiqiang Zhang, Aiqun Xu, Kaifeng Shen, Zhirong Yu, Lei Chen, Liang Correction: EGFR kinase domain mutation positive lung cancers are sensitive to intrapleural perfusion with hyperthermic chemotherapy (IPHC) complete treatment |
| title | Correction: EGFR kinase domain mutation positive lung cancers are sensitive to intrapleural perfusion with hyperthermic chemotherapy (IPHC) complete treatment |
| title_full | Correction: EGFR kinase domain mutation positive lung cancers are sensitive to intrapleural perfusion with hyperthermic chemotherapy (IPHC) complete treatment |
| title_fullStr | Correction: EGFR kinase domain mutation positive lung cancers are sensitive to intrapleural perfusion with hyperthermic chemotherapy (IPHC) complete treatment |
| title_full_unstemmed | Correction: EGFR kinase domain mutation positive lung cancers are sensitive to intrapleural perfusion with hyperthermic chemotherapy (IPHC) complete treatment |
| title_short | Correction: EGFR kinase domain mutation positive lung cancers are sensitive to intrapleural perfusion with hyperthermic chemotherapy (IPHC) complete treatment |
| title_sort | correction: egfr kinase domain mutation positive lung cancers are sensitive to intrapleural perfusion with hyperthermic chemotherapy (iphc) complete treatment |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219665/ https://www.ncbi.nlm.nih.gov/pubmed/30443297 http://dx.doi.org/10.18632/oncotarget.26255 |
| work_keys_str_mv | AT zhanghongjuan correctionegfrkinasedomainmutationpositivelungcancersaresensitivetointrapleuralperfusionwithhyperthermicchemotherapyiphccompletetreatment AT zhancheng correctionegfrkinasedomainmutationpositivelungcancersaresensitivetointrapleuralperfusionwithhyperthermicchemotherapyiphccompletetreatment AT keji correctionegfrkinasedomainmutationpositivelungcancersaresensitivetointrapleuralperfusionwithhyperthermicchemotherapyiphccompletetreatment AT xuezhiqiang correctionegfrkinasedomainmutationpositivelungcancersaresensitivetointrapleuralperfusionwithhyperthermicchemotherapyiphccompletetreatment AT zhangaiqun correctionegfrkinasedomainmutationpositivelungcancersaresensitivetointrapleuralperfusionwithhyperthermicchemotherapyiphccompletetreatment AT xukaifeng correctionegfrkinasedomainmutationpositivelungcancersaresensitivetointrapleuralperfusionwithhyperthermicchemotherapyiphccompletetreatment AT shenzhirong correctionegfrkinasedomainmutationpositivelungcancersaresensitivetointrapleuralperfusionwithhyperthermicchemotherapyiphccompletetreatment AT yulei correctionegfrkinasedomainmutationpositivelungcancersaresensitivetointrapleuralperfusionwithhyperthermicchemotherapyiphccompletetreatment AT chenliang correctionegfrkinasedomainmutationpositivelungcancersaresensitivetointrapleuralperfusionwithhyperthermicchemotherapyiphccompletetreatment |